Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $216,262 - $292,967
-1,825 Reduced 41.59%
2,563 $311,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $20,620 - $29,947
-152 Reduced 3.35%
4,388 $673,000
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $46,878 - $83,175
396 Added 9.56%
4,540 $815,000
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $59,979 - $98,643
-508 Reduced 10.92%
4,144 $490,000
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $94,523 - $142,508
807 Added 20.99%
4,652 $665,000
Q1 2022

May 11, 2022

BUY
$126.46 - $235.05 $54,630 - $101,541
432 Added 12.66%
3,845 $662,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $22,807 - $37,219
101 Added 3.05%
3,413 $867,000
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $94,529 - $206,384
426 Added 14.76%
3,312 $1.27 Million
Q2 2021

Aug 09, 2021

BUY
$129.91 - $234.98 $41,181 - $74,488
317 Added 12.34%
2,886 $678,000
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $280,483 - $477,782
2,569 New
2,569 $336,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Heritage Trust CO Portfolio

Follow Heritage Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Trust CO with notifications on news.